Jonathan Arnold

Insider profile

Currently holds a position at Catalent Inc

Performance

Overall performance
4.1

Performance over holding periods
4.1
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
President - Oral Drug Delivery Solutions Catalent Inc Oct. 1, 2017 -

Jonathan Arnold's trades of Catalent Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-08-25 2023-08-24 S Sale
56,561 +22.9%
79.22
US$2,887,151
56,561 +22.9% 79.22 US$2,887,151
2023-08-24 2023-08-24 PrS Proposed sale
93,048
384.66
US$1,077,695
93,048 384.66 US$1,077,695
2023-08-03 2023-08-01 S Sale
56,927 -48.1%
101.84
US$3,990,403
56,927 -48.1% 101.84 US$3,990,403
2023-08-01 2023-08-01 PrS Proposed sale
62
47.80
US$2,964
62 47.80 US$2,964
2022-08-26 2022-08-25 S Sale
384 -0.7%
103.04
US$39,567
384 -0.7% 103.04 US$39,567
2022-07-28 2022-07-26 S Sale
94 -0.2%
106.90
US$10,049
94 -0.2% 106.90 US$10,049
2021-11-03 2021-11-01 PlS Planned sale
10,672 -20.3%
140.02
US$1,494,293
10,672 -20.3% 140.02 US$1,494,293
2021-10-18 2021-10-14 PlS Planned sale
1,661 -3.6%
129.41
US$214,950
1,661 -3.6% 129.41 US$214,950
2021-01-05 2021-01-04 PlS Planned sale
16 -0.0%
104.42
US$1,671
16 -0.0% 104.42 US$1,671
2020-10-09 2020-10-07 PlS Planned sale
15,928 -29.2%
91.50
US$1,457,412
15,928 -29.2% 91.50 US$1,457,412